[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Abvc Biopharma Inc (ABVC)

Abvc Biopharma Inc (ABVC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
ABVC BioPharma Receives $200,000 Payment from OncoX BioPharma as Part of Strategic Licensing Agreement

ABVC BioPharma received a $200,000 payment from OncoX as part of a $5 million licensing agreement for oncology products.Quiver AI SummaryABVC BioPharma, Inc. has received a $200,000 payment from OncoX...

ABVC : 1.0100 (-4.72%)
Biotech Companies Making Strides in Pancreatic Cancer Treatment and Early Detection

/CNW/ -- USA News Group – Hope is rising in the fight against one of the deadliest cancers in the world, as a new study recently claimed that a blood test can...

ONCY : 0.7516 (-5.11%)
ABVC : 1.0100 (-4.72%)
CTMX : 3.17 (-1.55%)
CADL : 9.40 (-2.89%)
ONC.TO : 1.42 (+2.16%)
AMGN : 387.64 (-1.39%)
Biotech Innovations Drive Hope in Global Fight Against Pancreatic Cancer

USA News Group – Hope is rising in the fight against one of the deadliest cancers in the world, as a new study recently claimed that a blood test can accurately detect early-stage pancreatic cancer with...

ONCY : 0.7516 (-5.11%)
ABVC : 1.0100 (-4.72%)
CTMX : 3.17 (-1.55%)
CADL : 9.40 (-2.89%)
ONC.TO : 1.42 (+2.16%)
AMGN : 387.64 (-1.39%)
ABVC Biopharma (NASDAQ: ABVC) Inks Major Licensing Agreement with Xinnovation Therapeutics for ABV-1504 and ABV-1505

Landmark Licensing Deal for ABVC in China's Growing Healthcare Market ABVC Biopharma, Inc. (NASDAQ: ABVC), a pioneer in the development

ABVC : 1.0100 (-4.72%)
ABVC BioPharma Provides Vitargus® Update on Phase II Site Initiation Visit Conducted at Srinagarind Hospital in Thailand

/PRNewswire/ -- ABVC BioPharma, Inc. (NASDAQ: ABVC), a clinical-stage biopharmaceutical company developing therapeutic solutions in oncology/hematology, CNS,...

ABVC : 1.0100 (-4.72%)
ABVC BioPharma Receives Registration Approval for Maitake Mushroom Dietary Supplement by the Taiwan Ministry of Health and Welfare

/PRNewswire/ -- ABVC Biopharma, Inc. ("ABVC" or the "Company") (NASDAQ: ABVC), a clinical stage biopharmaceutical company developing therapeutic solutions in...

ABVC : 1.0100 (-4.72%)
ABVC BioPharma Provides Vitargus® Update

Phase II Vitargus® Clinical Study Protocol Receives Local Ethics Committee Approval FREMONT, CA, Aug. 02, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire...

ABVC : 1.0100 (-4.72%)

Barchart Exclusives

This Dividend Stock Is Up 22% in a Month Despite Mixed Q2 Earnings. Don’t Sell Just Yet.
Domino’s Pizza stock has rebounded sharply from its 2026 lows. While its valuation multiples have expanded and DPZ does not look as tempting now, dividend investors can stay put in the stock. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.